The Moving Average Convergence Divergence (MACD) for XROLF turned positive on January 08, 2025. Looking at past instances where XROLF's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 50 cases where XROLF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on January 07, 2025. You may want to consider a long position or call options on XROLF as a result. In of 58 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
XROLF moved above its 50-day moving average on January 07, 2025 date and that indicates a change from a downward trend to an upward trend.
The Aroon Indicator entered an Uptrend today. In of 287 cases where XROLF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XROLF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
XROLF broke above its upper Bollinger Band on January 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XROLF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.685) is normal, around the industry mean (31.386). XROLF has a moderately high P/E Ratio (1250.000) as compared to the industry average of (158.632). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.763). Dividend Yield (0.000) settles around the average of (0.084) among similar stocks. P/S Ratio (14.620) is also within normal values, averaging (58.815).
Industry PackagedSoftware
A.I.dvisor tells us that XROLF and FRGT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XROLF and FRGT's prices will move in lockstep.
Ticker / NAME | Correlation To XROLF | 1D Price Change % | ||
---|---|---|---|---|
XROLF | 100% | N/A | ||
FRGT - XROLF | 26% Poorly correlated | -2.16% | ||
ATEN - XROLF | 26% Poorly correlated | +1.28% | ||
NEOJF - XROLF | 21% Poorly correlated | N/A | ||
CRYBF - XROLF | 21% Poorly correlated | -2.58% | ||
XBP - XROLF | 20% Poorly correlated | -7.56% | ||
More |